Thrivent Financial for Lutherans lifted its holdings in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 95.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,816,217 shares of the real estate investment trust's stock after purchasing an additional 888,908 shares during the quarter. Thrivent Financial for Lutherans owned approximately 0.77% of Sabra Health Care REIT worth $31,457,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also modified their holdings of SBRA. Geode Capital Management LLC lifted its holdings in Sabra Health Care REIT by 1.7% in the 3rd quarter. Geode Capital Management LLC now owns 6,294,798 shares of the real estate investment trust's stock worth $117,165,000 after purchasing an additional 104,533 shares during the last quarter. JPMorgan Chase & Co. lifted its stake in shares of Sabra Health Care REIT by 222.4% in the third quarter. JPMorgan Chase & Co. now owns 9,886,917 shares of the real estate investment trust's stock worth $183,996,000 after buying an additional 6,819,919 shares during the last quarter. Vestcor Inc boosted its holdings in Sabra Health Care REIT by 62.5% during the third quarter. Vestcor Inc now owns 207,918 shares of the real estate investment trust's stock valued at $3,869,000 after acquiring an additional 79,956 shares during the period. Barclays PLC increased its stake in shares of Sabra Health Care REIT by 56.1% in the third quarter. Barclays PLC now owns 678,397 shares of the real estate investment trust's stock worth $12,624,000 after purchasing an additional 243,895 shares during the period. Finally, Franklin Resources Inc. lifted its position in shares of Sabra Health Care REIT by 12.3% during the 3rd quarter. Franklin Resources Inc. now owns 524,917 shares of the real estate investment trust's stock worth $9,543,000 after purchasing an additional 57,551 shares during the last quarter. Institutional investors own 99.40% of the company's stock.
Sabra Health Care REIT Price Performance
NASDAQ:SBRA traded down $0.20 during mid-day trading on Tuesday, hitting $17.15. The company's stock had a trading volume of 2,061,955 shares, compared to its average volume of 1,981,775. The company has a current ratio of 4.32, a quick ratio of 4.16 and a debt-to-equity ratio of 0.88. The stock has a fifty day moving average of $16.80 and a 200-day moving average of $17.68. The company has a market capitalization of $4.08 billion, a price-to-earnings ratio of 32.36, a P/E/G ratio of 1.97 and a beta of 1.27. Sabra Health Care REIT, Inc. has a fifty-two week low of $13.31 and a fifty-two week high of $20.03.
Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last issued its earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.36. The business had revenue of $182.35 million during the quarter, compared to analysts' expectations of $178.01 million. Sabra Health Care REIT had a return on equity of 4.60% and a net margin of 18.02%. As a group, equities analysts forecast that Sabra Health Care REIT, Inc. will post 1.45 EPS for the current fiscal year.
Sabra Health Care REIT Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Friday, February 14th were paid a dividend of $0.30 per share. The ex-dividend date was Friday, February 14th. This represents a $1.20 annualized dividend and a yield of 7.00%. Sabra Health Care REIT's dividend payout ratio is 226.42%.
Analyst Ratings Changes
SBRA has been the subject of a number of research reports. Mizuho reissued a "neutral" rating and issued a $20.00 price target on shares of Sabra Health Care REIT in a report on Thursday, December 5th. Citizens Jmp upgraded shares of Sabra Health Care REIT from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, January 7th. Truist Financial boosted their price target on Sabra Health Care REIT from $17.00 to $18.00 and gave the company a "hold" rating in a research note on Tuesday, March 18th. Finally, JMP Securities upgraded Sabra Health Care REIT from a "market perform" rating to an "outperform" rating and set a $20.00 price objective for the company in a research report on Tuesday, January 7th. Three research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, Sabra Health Care REIT currently has a consensus rating of "Moderate Buy" and a consensus target price of $19.33.
Get Our Latest Stock Analysis on Sabra Health Care REIT
Sabra Health Care REIT Company Profile
(
Free Report)
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
See Also
Before you consider Sabra Health Care REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Health Care REIT wasn't on the list.
While Sabra Health Care REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
